MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Gender Identity and Treatment Response in Patients with Functional Tic-Like Behavior

    S. Kola, D. Larson (Chicago, USA)

    Objective: The aim of this case series is to add to the limited existing reports on the demographics, clinical history, phenomenology, and treatment response of…
  • 2022 International Congress

    Does aging influence eating behavior during COVID-19 pandemic in patients with Parkinson’s Disease in northeastern Mexico?

    C. López Botello, S. Castillo Torres, I. Estrada Bellmann, B. Chávez Luevanos (Monterrey, Mexico)

    Objective: The aim of the study was to examine nutritional behavioral age-related impact in Parkinson's Disease patients. Background: COVID-19 caused serious psychological and nutritional impact.…
  • 2022 International Congress

    Neuroprotective effects of Ibudilast, a Phosphodiesterase IV inhibitor in mouse model of Parkinson’s disease

    M. Sarswati, A. Gaur (Delhi, India)

    Objective: In the present study, we examined neuroprotective effects, if any, of IBD drug, a  inhibitor of the phosphodiesterase IV in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse…
  • 2022 International Congress

    The brain-age framework in Parkinson’s disease: evaluating MRI morphometry and sex-dimorphism

    G. Gonzalez-Escamilla, P. Farag, M. Bange, S. Groppa (Mainz, Germany)

    Objective: We aimed to develop an MRI brain-age prediction (BAP) model to evaluate differences between Parkinson’s disease (PD) and healthy controls (HC). We further evaluated…
  • 2022 International Congress

    Cortical responses evoked by stimulation of the subthalamic nucleus for intraoperative target determination in deep brain stimulation

    M. Kersten, T. Kriesen, J. Heller, M. Löhle, A. Storch, R. Reese (Rostock, Germany)

    Objective: 1. Method development to routinely determine cortical responses evoked by stimulation of the subthalamic nucleus (STN-EP) during intraoperative electrode placement for STN deep brain…
  • 2022 International Congress

    C-SURF: DBS programming using probabilistic maps as an efficient new approach to treat patients with dystonia: the results of a feasibility study.

    F. Lange, M. Reich (Würzburg, Germany)

    Objective: To evaluate the clinical potential of a novel computer-guided prediction of optimal stimulation settings for pallidal DBS for the treatment of motor symptoms of…
  • 2022 International Congress

    Automated scoring of REM sleep without atonia using the open-source software RBDtector

    CEJ. Doppler, A. Röthenbacher, N. Okkels, N. Willemsen, N. Sembowski, AD. Seger, M. Lindner, C. Brune, S. Bialonski, P. Borghammer, GR. Fink, M. Schober, M. Sommerauer (Köln, Germany)

    Objective: To facilitate quantification of REM sleep without atonia (RSWA) and thereby identify patients with rapid eye movement (REM) sleep behaviour disorder (RBD). Background: RBD…
  • 2022 International Congress

    Addressing pathological alpha-synuclein aggregation using a small molecule strategy

    E. Tsika, N. Ait-Bouziad, N. Dreyfus, C. Vallet, L. Maliqi, L. Aeschbach, S. Pautet, S. Menant, I. Borovko, L. Rey-Bellet, A. Ouared, R. Migliorini, K. Piorkowska, V. Darmency, H. Kroth, S. Poli, A. Pfeifer, M. Kosco-Vilbois (Lausanne, Switzerland)

    Objective: The discovery of cell-permeable, orally bioavailable and brain penetrant small molecules with the potential of inhibiting aggregation and intracellular accumulation of pathological alpha-synuclein (a-syn)…
  • 2022 International Congress

    Can we add whey protein supplementation in patients with Parkinson’s disease without interfering with levodopa response?

    G. Pinelli, C. Siri, A. Ranghetti, V. Cereda, R. Maestri, M. Canesi (Gravedona, Italy)

    Objective: The main endpoint of the study was to evaluate if a daily intake of whey protein-based dietary supplement causes a worse response to levodopa…
  • 2022 International Congress

    NIMHANS Neuropsychological Battery for Elderly in Parkinson’s disease patients: Validation and diagnosis using MDS PD-MCI task force criteria in Indian population

    R. Yadav, R. Botta, K. Kumar, BM. Kutty, A. Mahadevan, PK. Pal (Bengaluru, India)

    Objective: To validate NIMHANS Neuropsychological Battery for Elderly( NNB-E) and evaluate cognitive impairment in Parkinson's disease (PD) patients in comparison with healthy controls. Background: Cognitive…
  • « Previous Page
  • 1
  • …
  • 141
  • 142
  • 143
  • 144
  • 145
  • …
  • 153
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley